City

Copenhagen (1)

Helsinki (1)

Seoul (1)

Condition

Acute Myeloid Leukemia (1)

Alzheimer's Disease (1)

Kidney Cancer (1)

Penile Cancer (1)

Prostate Cancer (1)

Prostate Carcinoma (1)

Testicular Cancer (1)

Urothelial Carcinoma (1)

Overall Status

Recruiting (2)

Not yet recruiting (1)

Unknown status (1)

Phase

n/a (2)

phase 2 (1)

phase 3 (1)

Sponsor

General University Hospital, Prague (1)

Helsinki University Central Hospital (1)

Rigshospitalet, Denmark (1)

Seoul National University Hospital (1)

Intervention

delayed salvage radiotherapy (dsrt) (1)

early salvage radiotherapy (esrt) (1)

personalised treatment (1)

rivastigmine (1)

venetoclax (1)

Study Documents

Intervention Type

drug (2)

other (1)

radiation (1)

Funder Type

Other (4)

Study Type

Interventional (4)

DSRT

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Prostate Cancer Trial (Early salvage radiotherapy (eSRT), Delayed Salvage radiotherapy (dSRT))

Not yet recruiting

Prostate Cancer

Early salvage radiotherapy (eSRT)
Delayed Salvage radiotherapy (dSRT)

(no location specified)

Aug 2, 2022

Prostate Carcinoma, Kidney Cancer, Urothelial Carcinoma Trial in Helsinki (Personalised treatment)

Recruiting

Prostate Carcinoma
+4 more

Personalised treatment

Helsinki, Uusimaa, Finland

Helsinki University Hospital

Mar 10, 2022

Acute Myeloid Leukemia Trial in Copenhagen (Venetoclax)

Recruiting

Acute Myeloid Leukemia

Venetoclax

Copenhagen, Denmark

Department of Hematology, Rigshospitalet

Jun 21, 2022

Alzheimer's Disease Trial in Seoul (Rivastigmine)

Unknown status

Alzheimer's Disease

Rivastigmine

Seoul, Korea, Republic of

Seoul Metropolitan Government Seoul National University Boramae

May 12, 2015